Loading...
Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab
PURPOSE: Phase III studies of bevacizumab in advanced pancreas cancer (APCA) demonstrated no improvement in outcome. No validated biomarkers for bevacizumab efficacy exist. We evaluated bevacizumab-related hypertension (B-HTN) as a biomarker in APCA patients in a pooled analysis from 4 prospective c...
Na minha lista:
| Udgivet i: | Am J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4305484/ https://ncbi.nlm.nih.gov/pubmed/25068471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000108 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|